Integra Lifesciences Holdings Corp (IART)
22.92
-0.01
(-0.04%)
USD |
NASDAQ |
Nov 21, 15:37
Integra Lifesciences Holdings Price to Book Value: 1.162 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 1.163 |
| November 19, 2024 | 1.160 |
| November 18, 2024 | 1.140 |
| November 15, 2024 | 1.160 |
| November 14, 2024 | 1.180 |
| November 13, 2024 | 1.182 |
| November 12, 2024 | 1.258 |
| November 11, 2024 | 1.291 |
| November 08, 2024 | 1.257 |
| November 07, 2024 | 1.294 |
| November 06, 2024 | 1.354 |
| November 05, 2024 | 1.263 |
| November 04, 2024 | 1.223 |
| November 01, 2024 | 0.9777 |
| October 31, 2024 | 0.951 |
| October 30, 2024 | 0.9875 |
| October 29, 2024 | 0.9885 |
| October 28, 2024 | 0.9794 |
| October 25, 2024 | 0.9606 |
| October 24, 2024 | 0.9571 |
| October 23, 2024 | 0.9687 |
| October 22, 2024 | 0.9728 |
| October 21, 2024 | 0.989 |
| October 18, 2024 | 1.007 |
| October 17, 2024 | 1.002 |
| Date | Value |
|---|---|
| October 16, 2024 | 1.004 |
| October 15, 2024 | 0.989 |
| October 14, 2024 | 0.9743 |
| October 11, 2024 | 0.9748 |
| October 10, 2024 | 0.9769 |
| October 09, 2024 | 0.9175 |
| October 08, 2024 | 0.8866 |
| October 07, 2024 | 0.8836 |
| October 04, 2024 | 0.8618 |
| October 03, 2024 | 0.8592 |
| October 02, 2024 | 0.878 |
| October 01, 2024 | 0.8871 |
| September 30, 2024 | 0.9211 |
| September 27, 2024 | 0.9037 |
| September 26, 2024 | 0.8834 |
| September 25, 2024 | 0.8667 |
| September 24, 2024 | 0.9042 |
| September 23, 2024 | 0.887 |
| September 20, 2024 | 0.8799 |
| September 19, 2024 | 0.8834 |
| September 18, 2024 | 0.8865 |
| September 17, 2024 | 0.8678 |
| September 16, 2024 | 0.8758 |
| September 13, 2024 | 0.8834 |
| September 12, 2024 | 0.8925 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.8592
Minimum
Oct 03 2024
4.236
Maximum
Apr 27 2021
2.727
Average
2.834
Median
Nov 04 2020
Price to Book Value Benchmarks
| Boston Scientific Corp | 6.518 |
| Haemonetics Corp | 4.904 |
| ResMed Inc | 6.873 |
| Globus Medical Inc | 2.833 |
| Perspective Therapeutics Inc | 0.6317 |
Price to Book Value Related Metrics
| PS Ratio | 1.134 |
| Price to Free Cash Flow | 46.64 |
| Price | 22.92 |
| Earnings Yield | -0.39% |
| Market Cap | 1.769B |
| Operating PE Ratio | 61.53 |